Viewing Study NCT01889420


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-16 @ 1:33 AM
Study NCT ID: NCT01889420
Status: TERMINATED
Last Update Posted: 2015-07-31
First Post: 2013-06-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: New Mexico Cancer Research Alliance
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: INST 1304
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View